Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Open Forum Infectious Diseases|February 5, 2020
Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed ViremiaAurelie Gouel-Cheron, Martha Nason, Adam Rupert, et al.
The Journal of Infectious Diseases|November 5, 2013
Evidence for innate immune system activation in HIV type 1-infected elite controllersSonya Krishnan, Eleanor M P Wilson, Virginia Sheikh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2006
Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapySarah W Read, Jeanette Higgins, Julia A Metcalf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2015
A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRISDenise C Hsu, Kimberly F Faldetta, Luxin Pei, et al.
AIDS (London, England)|March 12, 2021
Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiationZeping Wang, Maura M Manion, Elizabeth Laidlaw, et al.
AIDS (London, England)|October 22, 2019
Plasma tissue factor and immune activation are associated with carotid intima-media thickness progression in treated HIV infectionDenise C Hsu, Yi Fei Ma, Amrit Narwan, et al.
AIDS (London, England)|May 28, 2010
Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infectionEmily S Ford, Jamieson H Greenwald, Aaron G Richterman, et al.
Blood|June 28, 2024
Inflammasome activation in patients with Kaposi sarcoma herpesvirus-associated diseasesSilvia Lucena Lage, Ramya Ramaswami, Joseph M Rocco, et al.
AIDS (London, England)|May 14, 2016
Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapyDenise C Hsu, Yi Fei Ma, Sophia Hur, et al.
AIDS Research and Human Retroviruses|April 29, 2015
Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected PatientsPhilip M Grant, Virginia Sheikh, Rebecca DerSimonian, et al.
Pageof 8